Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Parallel Bio Introduces Novel Clinical Trial Methodology Using Organoids for Accelerated Drug Discovery

Friday, May 17, 2024

Parallel Bio a pioneering biotech company focused on leveraging the immune system to combat diseases has introduced its latest innovation the Clinical Trial in a Dish This revolutionary

Voyager Therapeutics Doses First Participants in VY-TAU01 Trial for Alzheimer’s Disease

Friday, May 17, 2024

Voyager Therapeutics Inc a biotech company focused on neurogenetic medicines announced the dosing of the first participants in its Phase a single ascending dose trial of VYTAU

Ractigen Therapeutics Receives Approval from China’s NMPA to Commence Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients

Thursday, May 16, 2024

Ractigen Therapeutics a leading clinicalstage pharmaceutical company dedicated to developing innovative therapies has announced a significant achievement the approval of its Investigational New Drug

Arexvy, the First RSV Vaccine for Older Adults, Granted Approval by HSA

Thursday, May 16, 2024

Arexvy the worlds first respiratory syncytial virus vaccine has recently gained approval from the Health Sciences Authority of Singapore for immunizing individuals aged years and above against lower respiratory tract disease caused by RSV This groun...

Ocugen Completes Dosing of Stargardt Disease Patients in Phase 1/2 GARDIAN Trial for OCU410ST Gene Therapy

Thursday, May 16, 2024

Ocugen Inc a biotechnology company focused on developing novel gene and cell therapies as well as vaccines has announced the completion of dosing in the second cohort of its Phase GARDian clinical trial

Everest Medicines Introduces NEFECON® to Mainland China with Commercial Launch and First Prescription

Wednesday, May 15, 2024

Everest Medicines a biopharmaceutical company dedicated to advancing medicines and vaccines has announced the successful launch of NEFECON in China marking a significant advancement

Zai Lab's Application for Priority Review of Efgartigimod Alfa Injection Accepted for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China

Wednesday, May 15, 2024

Zai Lab Limited has announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted the supplemental Biologics License Application

Mabwell Updates on Clinical Trial Development of 9MW2821 for Triple-Negative Breast Cancer

Tuesday, May 14, 2024

Mabwell an innovative biopharmaceutical company with a comprehensive industry chain has provided updates on the clinical study progress of its groundbreaking ADC targeting Nectin for triplenegative

HUTCHMED Commences RAPHAEL Registrational Phase III Trial of HMPL-306 for Chinese Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia

Tuesday, May 14, 2024

HUTCHMED Limited has initiated a Phase III clinical trial for HMPL in Chinese patients with relapsed

Launch of Tiopronin Delayed-Release Tablets with Patient Support for Cystinuria Treatment in the United States

Tuesday, May 14, 2024

Cycle Pharmaceuticals Limited is excited to introduce tiopronin delayedrelease tablets as a treatment option for individuals with cystinuria Tiopronin delayedrelease tablets come in mg and mg doses

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024